8-K: Cartesian Growth Corporation II Enters Non-Binding Letter of Intent for Business Combination

Cartesian Growth Corporation II has signed a non-binding letter of intent with a potential target in the risk-reduction products sector, aiming for a business combination.

Summary

• Cartesian Growth Corporation II has entered into a non-binding letter of intent with a potential target in the risk-reduction products sector.
• The potential target is expected to be a market-leading company with international operations.
• The target is projected to have a pro forma adjusted EBITDA of more than $100 million in 2025.
• The adjusted EBITDA is not an IFRS or GAAP measure and cannot be reconciled without unreasonable effort.
• There is no guarantee that a definitive agreement will be reached or that the business combination will be completed.
• The transaction is subject to board and stakeholder approvals, regulatory approvals, and other customary closing conditions.

Sentiment

Score: 6

Explanation: The sentiment is cautiously optimistic. The announcement of a potential merger is positive, but the non-binding nature of the agreement and the lack of a definitive deal temper the enthusiasm.

Positives

• The potential business combination could create a market-leading company in the risk-reduction products sector.
• The target company is expected to have a strong financial performance with a projected adjusted EBITDA exceeding $100 million in 2025.

Negatives

• The letter of intent is non-binding, and there is no guarantee that a definitive agreement will be reached.
• The adjusted EBITDA is not a standard accounting measure and cannot be easily reconciled.
• The transaction is subject to various approvals and conditions, which could delay or prevent the deal from closing.

Risks

• There is a risk that a definitive agreement will not be reached with the potential target.
• The business combination may not be completed due to various approvals and conditions.
• The financial performance of the potential target may not meet the projected adjusted EBITDA.
• The company's termination date could impact the ability to complete the transaction.

Future Outlook

The company is hopeful that it can consummate an initial business combination with the potential target, but there is no guarantee of success. The company undertakes no obligation to update or revise the forward-looking statements.

Management Comments

• The company is hopeful that it can consummate an initial business combination with the Potential Target.
• The company is unable to provide a reconciliation of adjusted EBITDA as it is not reconcilable to its most directly comparable IFRS or GAAP measure without unreasonable efforts.

Industry Context

This announcement indicates a move by Cartesian Growth Corporation II to acquire a company in the risk-reduction products sector, which is a growing market. This is a common strategy for SPACs seeking to merge with a private company.

Comparison to Industry Standards

• The projected adjusted EBITDA of over $100 million for the potential target is a significant figure, suggesting a substantial business.
• Comparable companies in the risk-reduction sector include those involved in safety equipment, environmental protection, and health-related products.
• The success of this deal will depend on the final terms and the ability to integrate the target company effectively.

Stakeholder Impact

• Shareholders may see a positive impact if the business combination is successful.
• Employees of both companies may experience changes as a result of the merger.
• Customers of the potential target may see changes in products or services.
• Suppliers and creditors may be affected by the new combined entity.

Next Steps

• The company will attempt to negotiate a definitive business combination agreement with the potential target.
• The company will seek board and stakeholder approvals for the transaction.
• The company will work to obtain necessary regulatory approvals.
• The company will file a definitive proxy statement with the SEC.

Key Dates

Keywords

business combination, risk-reduction products, adjusted EBITDA, letter of intent, merger, acquisition, Cartesian Growth Corporation II